These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 18054942)

  • 1. Effect of pioglitazone on progression of subclinical atherosclerosis in non-diabetic premenopausal Hispanic women with prior gestational diabetes.
    Xiang AH; Hodis HN; Kawakubo M; Peters RK; Kjos SL; Marroquin A; Goico J; Ochoa C; Liu CR; Liu CH; Buchanan TA
    Atherosclerosis; 2008 Jul; 199(1):207-14. PubMed ID: 18054942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of pioglitazone on pancreatic beta-cell function and diabetes risk in Hispanic women with prior gestational diabetes.
    Xiang AH; Peters RK; Kjos SL; Marroquin A; Goico J; Ochoa C; Kawakubo M; Buchanan TA
    Diabetes; 2006 Feb; 55(2):517-22. PubMed ID: 16443789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of thiazolidinedione treatment on progression of subclinical atherosclerosis in premenopausal women at high risk for type 2 diabetes.
    Xiang AH; Peters RK; Kjos SL; Ochoa C; Marroquin A; Goico J; Tan S; Wang C; Azen SP; Liu CR; Liu CH; Hodis HN; Buchanan TA
    J Clin Endocrinol Metab; 2005 Apr; 90(4):1986-91. PubMed ID: 15623809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRIPOD (TRoglitazone In the Prevention Of Diabetes): a randomized, placebo-controlled trial of troglitazone in women with prior gestational diabetes mellitus.
    Azen SP; Peters RK; Berkowitz K; Kjos S; Xiang A; Buchanan TA
    Control Clin Trials; 1998 Apr; 19(2):217-31. PubMed ID: 9551285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pioglitazone slows progression of atherosclerosis in prediabetes independent of changes in cardiovascular risk factors.
    Saremi A; Schwenke DC; Buchanan TA; Hodis HN; Mack WJ; Banerji M; Bray GA; Clement SC; Henry RR; Kitabchi AE; Mudaliar S; Ratner RE; Stentz FB; Musi N; Tripathy D; DeFronzo RA; Reaven PD
    Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):393-9. PubMed ID: 23175674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of pioglitazone compared with glimepiride on carotid intima-media thickness in type 2 diabetes: a randomized trial.
    Mazzone T; Meyer PM; Feinstein SB; Davidson MH; Kondos GT; D'Agostino RB; Perez A; Provost JC; Haffner SM
    JAMA; 2006 Dec; 296(21):2572-81. PubMed ID: 17101640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of troglitazone on insulin sensitivity and pancreatic beta-cell function in women at high risk for NIDDM.
    Berkowitz K; Peters R; Kjos SL; Goico J; Marroquin A; Dunn ME; Xiang A; Azen S; Buchanan TA
    Diabetes; 1996 Nov; 45(11):1572-9. PubMed ID: 8866563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased high-density lipoprotein cholesterol predicts the pioglitazone-mediated reduction of carotid intima-media thickness progression in patients with type 2 diabetes mellitus.
    Davidson M; Meyer PM; Haffner S; Feinstein S; D'Agostino R; Kondos GT; Perez A; Chen Z; Mazzone T
    Circulation; 2008 Apr; 117(16):2123-30. PubMed ID: 18413496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological treatment of insulin resistance at two different stages in the evolution of type 2 diabetes: impact on glucose tolerance and beta-cell function.
    Xiang AH; Peters RK; Kjos SL; Goico J; Ochoa C; Marroquin A; Tan S; Hodis HN; Azen SP; Buchanan TA
    J Clin Endocrinol Metab; 2004 Jun; 89(6):2846-51. PubMed ID: 15181067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of antihypertensive therapy on progression of carotid intima-media thickness in patients with type 2 diabetes mellitus.
    Zheng L; Hodis HN; Buchanan TA; Li Y; Mack WJ
    Am J Cardiol; 2007 Apr; 99(7):956-60. PubMed ID: 17398191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women.
    Buchanan TA; Xiang AH; Peters RK; Kjos SL; Marroquin A; Goico J; Ochoa C; Tan S; Berkowitz K; Hodis HN; Azen SP
    Diabetes; 2002 Sep; 51(9):2796-803. PubMed ID: 12196473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in insulin sensitivity in response to troglitazone do not differ between subjects with and without the common, functional Pro12Ala peroxisome proliferator-activated receptor-gamma2 gene variant: results from the Troglitazone in Prevention of Diabetes (TRIPOD) study.
    Snitker S; Watanabe RM; Ani I; Xiang AH; Marroquin A; Ochoa C; Goico J; Shuldiner AR; Buchanan TA;
    Diabetes Care; 2004 Jun; 27(6):1365-8. PubMed ID: 15161789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of type 2 diabetes with troglitazone in the Diabetes Prevention Program.
    Knowler WC; Hamman RF; Edelstein SL; Barrett-Connor E; Ehrmann DA; Walker EA; Fowler SE; Nathan DM; Kahn SE;
    Diabetes; 2005 Apr; 54(4):1150-6. PubMed ID: 15793255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substitution of pioglitazone for troglitazone in patients with type 2 diabetes.
    Kane MP; Busch RS; Bakst G; Hamilton RA
    Endocr Pract; 2004; 10(1):18-23. PubMed ID: 15251617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pioglitazone versus glimepiride on coronary artery calcium progression in patients with type 2 diabetes mellitus: a secondary end point of the CHICAGO study.
    Davidson MH; Beam CA; Haffner S; Perez A; D'Agostino R; Mazzone T
    Arterioscler Thromb Vasc Biol; 2010 Sep; 30(9):1873-6. PubMed ID: 20576945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early onset of subclinical atherosclerosis in women with gestational diabetes mellitus.
    Tarim E; Yigit F; Kilicdag E; Bagis T; Demircan S; Simsek E; Haydardedeoglu B; Yanik F
    Ultrasound Obstet Gynecol; 2006 Feb; 27(2):177-82. PubMed ID: 16435313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The novel hypoglycemic agent YM440 normalizes hyperglycemia without changing body fat weight in diabetic db/db mice.
    Shimaya A; Kurosaki E; Nakano R; Hirayama R; Shibasaki M; Shikama H
    Metabolism; 2000 Mar; 49(3):411-7. PubMed ID: 10726922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pioglitazone hydrochloride in combination with metformin in the treatment of type 2 diabetes mellitus: a randomized, placebo-controlled study. The Pioglitazone 027 Study Group.
    Einhorn D; Rendell M; Rosenzweig J; Egan JW; Mathisen AL; Schneider RL
    Clin Ther; 2000 Dec; 22(12):1395-409. PubMed ID: 11192132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of effects of thiazolidinediones on cardiovascular risk factors: observations from a clinical practice.
    Gegick CG; Altheimer MD
    Endocr Pract; 2001; 7(3):162-9. PubMed ID: 11421562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preventing progression from gestational diabetes mellitus to diabetes: A thought-filled review.
    Kasher-Meron M; Grajower MM
    Diabetes Metab Res Rev; 2017 Oct; 33(7):. PubMed ID: 28544499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.